Pharmacometrics Meets Statistics: Building Bridges for Modern Drug Development

Includes a Live Web Event on 07/09/2026 at 12:00 PM (EDT)

Pharmacometrics Meets Statistics: Building Bridges for Modern Drug Development - This presentation explores the complementary strengths of statistical and pharmacometric (PMx) approaches in clinical drug development. We will gain insight into how integrating these two quantitative disciplines – from exposure-response modeling and model-based meta-analysis to optimal designs and PK bridging studies – can yield more robust, efficient, and scientifically rigorous development programs. Through three worked examples, the presentation demonstrates that collaboration between statisticians and pharmacometricians produces outcomes neither discipline could achieve alone.

Alex Sverdlov

Senior Director

Novartis

• PhD biostatistics leader with over 18 years of research and development experience in biopharmaceutical industry, in various roles with increasing responsibilities.

• Passionate for complex problem solving and integration of different fields and functions across the biopharmaceutical development continuum.

• Strategic and managerial experience of teams of statisticians and programmers to support multiple programs/indications of various complexity.

• Out-of-the-box thinker and reliable team player with excellent stakeholder management, communication, analytical, computational and technical writing skills.

• Lifelong learner and entrepreneur with original research and publications on adaptive designs for clinical research.

• Hands on statistical modeling, complex data analysis and simulations; proficiency in SAS and R; very good knowledge of the regulatory landscape.